Business Wire
BusinessEli Lilly’s reported $2.9B Merida acquisition sparks M&A chatter as SLS and IBRX rebound after AugustThe Apex TimesBusinessElon Musk’s chip preference spotlights Nvidia’s edge over AMD, but investors still watch executionThe Apex TimesBusinessTesla shares outpaced Rivian and Chinese EV rivals in August as Robotaxi rollout inched higher, traders looked ahead to the next Cybercab pushThe Apex TimesBusinessModerna shares surge 156% in August as investors bet on clinical progressThe Apex TimesBusinessMing-Chi Kuo says Nvidia has revived Rubin CPX after it seemingly vanished from the AI roadmapThe Apex TimesBusinessApple’s next CEO arrives with a different kind of power: money, and an AI testThe Apex TimesBusinessTesla and Einride set first 2026 delivery timeline for 500 Semi trucksThe Apex TimesBusinessZonPrep buys inbound-inventory software and services, betting on Amazon logistics automationThe Apex TimesBusinessNvidia pauses part of its AI customer financing after a strong quarter, raising questions about timingThe Apex TimesBusinessBoeing Teams With Thailand’s Civil Aviation Authority to Roll Out Competency-Based Pilot Training Across the CountryThe Apex TimesBusinessApple CEO transition hands AI test to John Ternus as AAPL slipsThe Apex TimesBusinessAnthropic reportedly signs $35 billion cloud deal involving Nvidia-backed Lambda and a Texas data-center leaseThe Apex TimesBusinessEli Lilly’s reported $2.9B Merida acquisition sparks M&A chatter as SLS and IBRX rebound after AugustThe Apex TimesBusinessElon Musk’s chip preference spotlights Nvidia’s edge over AMD, but investors still watch executionThe Apex TimesBusinessTesla shares outpaced Rivian and Chinese EV rivals in August as Robotaxi rollout inched higher, traders looked ahead to the next Cybercab pushThe Apex TimesBusinessModerna shares surge 156% in August as investors bet on clinical progressThe Apex TimesBusinessMing-Chi Kuo says Nvidia has revived Rubin CPX after it seemingly vanished from the AI roadmapThe Apex TimesBusinessApple’s next CEO arrives with a different kind of power: money, and an AI testThe Apex TimesBusinessTesla and Einride set first 2026 delivery timeline for 500 Semi trucksThe Apex TimesBusinessZonPrep buys inbound-inventory software and services, betting on Amazon logistics automationThe Apex TimesBusinessNvidia pauses part of its AI customer financing after a strong quarter, raising questions about timingThe Apex TimesBusinessBoeing Teams With Thailand’s Civil Aviation Authority to Roll Out Competency-Based Pilot Training Across the CountryThe Apex TimesBusinessApple CEO transition hands AI test to John Ternus as AAPL slipsThe Apex TimesBusinessAnthropic reportedly signs $35 billion cloud deal involving Nvidia-backed Lambda and a Texas data-center leaseThe Apex TimesBusinessEli Lilly’s reported $2.9B Merida acquisition sparks M&A chatter as SLS and IBRX rebound after AugustThe Apex TimesBusinessElon Musk’s chip preference spotlights Nvidia’s edge over AMD, but investors still watch executionThe Apex TimesBusinessTesla shares outpaced Rivian and Chinese EV rivals in August as Robotaxi rollout inched higher, traders looked ahead to the next Cybercab pushThe Apex TimesBusinessModerna shares surge 156% in August as investors bet on clinical progressThe Apex TimesBusinessMing-Chi Kuo says Nvidia has revived Rubin CPX after it seemingly vanished from the AI roadmapThe Apex TimesBusinessApple’s next CEO arrives with a different kind of power: money, and an AI testThe Apex TimesBusinessTesla and Einride set first 2026 delivery timeline for 500 Semi trucksThe Apex TimesBusinessZonPrep buys inbound-inventory software and services, betting on Amazon logistics automationThe Apex TimesBusinessNvidia pauses part of its AI customer financing after a strong quarter, raising questions about timingThe Apex TimesBusinessBoeing Teams With Thailand’s Civil Aviation Authority to Roll Out Competency-Based Pilot Training Across the CountryThe Apex TimesBusinessApple CEO transition hands AI test to John Ternus as AAPL slipsThe Apex TimesBusinessAnthropic reportedly signs $35 billion cloud deal involving Nvidia-backed Lambda and a Texas data-center leaseThe Apex TimesBusinessEli Lilly’s reported $2.9B Merida acquisition sparks M&A chatter as SLS and IBRX rebound after AugustThe Apex TimesBusinessElon Musk’s chip preference spotlights Nvidia’s edge over AMD, but investors still watch executionThe Apex TimesBusinessTesla shares outpaced Rivian and Chinese EV rivals in August as Robotaxi rollout inched higher, traders looked ahead to the next Cybercab pushThe Apex TimesBusinessModerna shares surge 156% in August as investors bet on clinical progressThe Apex TimesBusinessMing-Chi Kuo says Nvidia has revived Rubin CPX after it seemingly vanished from the AI roadmapThe Apex TimesBusinessApple’s next CEO arrives with a different kind of power: money, and an AI testThe Apex TimesBusinessTesla and Einride set first 2026 delivery timeline for 500 Semi trucksThe Apex TimesBusinessZonPrep buys inbound-inventory software and services, betting on Amazon logistics automationThe Apex TimesBusinessNvidia pauses part of its AI customer financing after a strong quarter, raising questions about timingThe Apex TimesBusinessBoeing Teams With Thailand’s Civil Aviation Authority to Roll Out Competency-Based Pilot Training Across the CountryThe Apex TimesBusinessApple CEO transition hands AI test to John Ternus as AAPL slipsThe Apex TimesBusinessAnthropic reportedly signs $35 billion cloud deal involving Nvidia-backed Lambda and a Texas data-center leaseThe Apex Times
Back to front
Park Ha Biological Technology says its North American Amazon store received official approval
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jul 6, 2:29 PM EDT

Park Ha Biological Technology says its North American Amazon store received official approval

The Wuxi, China-based company, which trades on NASDAQ under the ticker BYAH, said it has cleared what it described as a rigorous review for its U.S. retail presence on Amazon, positioning the move as a step toward broader brand globalization.

Park Ha Biological Technology Co., Ltd., a Wuxi, China-based life sciences company that trades on the NASDAQ under the ticker BYAH, said it has received official approval for its North American Amazon store. The announcement, dated July 6, 2026, frames the milestone as a “new era of brand globalization,” suggesting the company sees Amazon’s North American marketplace as an important distribution and brand-building channel.

According to the company’s release carried by Yahoo Finance, Park Ha Biological said it “successfully passed the comprehensive and rigorous” process tied to the Amazon store approval. While the announcement emphasizes the thoroughness of the review, the public posting provided does not specify the nature of the approval, such as which Amazon program or compliance requirements it involved, or the timing of prior store setup steps.

Amazon operates marketplaces that allow brands and sellers to list products for sale to customers in multiple regions. In practice, obtaining approval to operate a store can involve meeting marketplace policies and product listing requirements, particularly for categories that face stricter review. However, the Park Ha disclosure did not enumerate any Amazon policy categories, documentation submissions, or conditions tied to the approval.

The company did not provide product-level detail in the excerpted report. It did not identify the specific brands, product SKUs, or product categories associated with the North American Amazon store, nor did it state expected timelines for new listings, inventory flow, or marketing plans following approval.

Park Ha Biological’s positioning of the approval as a globalization step reflects a broader pattern in cross-border e-commerce, where brands use established platforms to reach customers without building every element of their own retail infrastructure locally. Amazon’s own newsroom materials describe how the company connects customers with sellers and brands across its ecosystem, which can help smaller companies expand distribution beyond their home markets when they can satisfy marketplace requirements.

Still, the announcement is notably light on operational specifics. The public post does not say whether the North American store is operated directly by Park Ha, by a partner or distributor, or through a third-party seller arrangement. It also does not disclose whether any regulatory or certification issues relevant to the company’s sector were part of the review.

What to watch next is whether Park Ha provides further updates on product launches tied to the store approval, including when listings go live, what countries the store serves, and whether the company reports any resulting sales traction. Investors and business observers may also look for follow-on communications that clarify the approval scope and any ongoing compliance obligations the company must meet to keep the store operational.

Why It Matters

  • An approved Amazon presence can broaden distribution reach for international brands, potentially lowering barriers to entering or expanding in North American retail.
  • Approval milestones can also announcement that a company has met marketplace requirements, which may reduce the risk of listing delays or suspension.
  • If Park Ha follows up with sales and launch updates, investors may gain a clearer view of whether platform-driven distribution contributes meaningfully to revenue.
  • The lack of granular disclosure means the market still lacks detail on scope, which could affect how quickly the company’s expansion translates into results.

Sources

Key Facts

  • Park Ha Biological Technology Co., Ltd. said it received official approval for its North American Amazon store.
  • The announcement was published July 6, 2026, and carried by Yahoo Finance.
  • Park Ha Biological trades on NASDAQ under the ticker BYAH.
  • The company characterized the approval process as comprehensive and rigorous, and described the result as a step toward brand globalization.
  • The publicly available posting did not list product categories, timelines for store launches, or operational details about how the store will be run.

Technology Related

Sep 1, 12:07 AM EDT
The Apex Times

Apple CEO transition hands AI test to John Ternus as AAPL slips

John Ternus takes over as Apple’s chief executive role as Phil Schiller steps back, with market attention focused on how leadership changes could affect ongoing work on artificial intelligence initiatives. Apple shares slid in early trading following the transition reports.

Apple CEO transition hands AI test to John Ternus as AAPL slips
The Apex Times
Park Ha Biological Technology says its North American Amazon store received official approval | The Apex Times